Both in Pharmaceuticals
Moleculin Biotech vs CalciMedica
Over the past year MBRX returned −95.7% and CALC returned −89.6%; their daily moves had a correlation of -0.08.
MBRX −95.7% CALC −89.6%Growth of $1, one year, split-adjusted
| Metric | MBRX | CALC |
|---|---|---|
| Price | $0.5264 | $1.61 |
| Market cap | $10.7M | $11.0M |
| Today | −7.49% | −4.17% |
| 1 month | −19.0% | −86.1% |
| 6 months | −76.5% | −38.1% |
| Year to date | −84.1% | −95.1% |
| 1 year | −95.7% | −89.5% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $7.3M | $9.4M |
| Dividend yield | — | — |
| Volatility (60d) | 249.6% | 490.0% |
| Short % of float | 1.6% | 2.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).